Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)’s Chief Executive Officer D Marc Beer has acquired 10,000 shares of common stock, at an average price of $30.12 per share. These shares were purchased in multiple transactions at prices ranging from $29.88 to $30.81. Following these transactions, Mr. Beer has 69,400 direct shares at this $950 million market cap biopharmaceutical company, and owns as well another 246,462 shares, through several indirect holdings.
Insiders at Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) have been active during first two quarters 2014. Mr. Beer has acquired 60,000 shares at prices ranging from $35.31 to $ 30.12 per share, and Director Anne Vanlent procured as well 4,000 shares at prices ranging from $ 33.20 to $ 35.29 per share.
Additionally, two important hedge funds have recently started investing in Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR): Jerome Pfund And Michael Sjostrom’s Sectoral Asset Management is currently holding 934,100 shares, worth $43,137 million, and representing 1.77% of its Equity Portfolio, and Sean Cullinan’s Point State Capital, with 925,000 shares, valued at $42,717 million. Moreover, Consonance Capital Management, Mitchell Blutt’s hedge fund, has increased its stake at the company by 41%, holding now 758,970 shares, worth $35,049 million, amount that represents 5.21% of its Equity Portfolio.
Disclosure: none
Suggested Reading:
10 Countries with Cheapest Medical Care
The 5 Best Paying Medical Jobs with Least Education
